Global OV Therapy Market - Industry Analysis Size Share Growth Trends and Forecast 2024 - 2031

Product Description

Oncolytic virus therapy is an exciting and increasingly recognized discipline in cancer research. Although the link between the virus and cancer regression was recognized in the early 20th century, viral therapy was used to attack and destroy cancer cells, and until recently, advanced genetic engineering techniques were developed. The OV Therapy market revenue was xx Million USD in 2019, grew to xx Million USD in 2023, and will reach xx Million USD in 2031, with a CAGR of xx during 2024-2031. Considering the influence of COVID-19 on the global OV Therapy market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions. This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery. Under COVID-19 Outbreak, how the OV Therapy Industry will develop is also analyzed in detail in Chapter 1.8 of this report. Major Players in OV Therapy market are: Viralytics Transgene SA Amgen Vyriad Targovax Oncolytics Biotech Lokon Pharma Oncolys BioPharma Sorrento Therapeutics Cold Genesys SillaJen Biotherapeutics Genelux Corporation TILT Biotherapeutics PsiOxus Therapeutics Most important types of OV Therapy products covered in this report are: HSV-based Oncolytic Viruses Adenoviruses-based Oncolytic Viruses Vaccinia Virus-based Oncolytic Viruses Vesicular Stomatitis Virus-based Oncolytic Viruses Newcastle Disease Virus-based Oncolytic Viruses Most widely used downstream fields of OV Therapy market covered in this report are: Melanoma Prostate Cancer Breast Cancer Ovarian Cancer Others Major Regions or countries covered in this report: North America Europe China Japan Middle East and Africa South America India South Korea Southeast Asia Others In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations. In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out. In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.